← Guides

Creatine EU Compliance: EFSA Claims, Novel Food and Labelling (2026)

Last updated 7 July 2026

The EU rules for creatine: authorized EFSA claim wording, novel food status, national limits, and food business obligations.

Creatine monohydrate is an established EU food supplement ingredient, and the rules that govern it are public and specific: two authorized EFSA health claims with exact wording, confirmed non-novel status for standard and micronized monohydrate, and national limits and notification rules that vary by member state. Getting these right is both a compliance requirement and a credibility signal to buyers.

The two authorized health claims (exact wording matters)

  • Physical performance (Regulation (EU) 432/2012): “Creatine increases physical performance in successive bursts of short-term, high intensity exercise.” Conditional on a daily intake of 3 g.
  • Muscle strength in older adults (Regulation (EU) 2017/672): a strength claim for adults over 55 in combination with resistance training, at 3 g per day plus regular resistance exercise.

These must be reproduced as authorized. Anything stronger, including any absorption or bioavailability claim tied to fine mesh or a novel form, is not authorized (see ultra-fine 500 mesh for why fineness is a formulation benefit, not an efficacy one).

Novel food status

Standard creatine monohydrate is not a novel food. Micronized creatine monohydrate was confirmed as not novel in 2025, which matters for brands using fine grades. Newer forms (HCl, buffered, esters) can still trigger novel food questions, one more reason monohydrate remains the default (see types of creatine).

National limits and food business obligations

  • National limits vary. France has applied a maximum around 3,000 mg per day in food supplements; other member states differ. Check the destination market.
  • Food business operator status. As a trader or brand you are a food business operator: registration with the competent authority and HACCP-based procedures apply, even for pure B2B distribution.
  • Per-country notification. Creatine is an other substance under the supplements directive, so notification rules differ by market.

Almost no supplier documents this clearly, which is exactly why it matters. Creavante sources with these rules in mind and supports customers on labelling and per-country requirements. For the quality side, see creatine purity and impurities.

Frequently asked

What health claims can creatine products make in the EU?

Two authorized claims exist. Under Regulation (EU) 432/2012, creatine increases physical performance in successive bursts of short-term high-intensity exercise, conditional on a 3 g daily intake. Under Regulation (EU) 2017/672, a muscle-strength claim for adults over 55 combined with regular resistance training. Wording must follow the register exactly, and no absorption or bioavailability claim is authorized for particle size or form.

Is creatine a novel food in the EU?

Standard creatine monohydrate is an established food supplement ingredient and is not a novel food. Micronized creatine monohydrate was confirmed as not novel in 2025. Newer or less established creatine forms can still raise novel food questions, which is another reason most brands stay with monohydrate.

Are there national limits on creatine in the EU?

Yes, member-state rules vary. France, for example, has applied a maximum around 3,000 mg per day in food supplements. Because creatine is treated as an other substance under the supplements directive, per-country notification and limits differ, so check the destination market.

Want it in your product?

Get a free sample →